Statement Of Cash Flows [Abstract]

Biofrontera AG - Filing #6464128

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
2,539 EUR
1,905 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
210,000 EUR
912,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
3,343 EUR
0 EUR
Payments of lease liabilities, classified as financing activities
464,000 EUR
467,000 EUR
Interest paid, classified as financing activities
53,000 EUR
12,000 EUR
Cash flows from (used in) financing activities
2,793 EUR
479,000 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
44,000 EUR
3,296 EUR
Cash and cash equivalents
3,124 EUR
3,080 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.